Evaluation of the Safety and the Tolerability of Durvalumab Plus Tremelimumab Combined With FOLFOX in mCRC
Conditions
- Colorectal Cancer Metastatic
Interventions
- DRUG: Durvalumab, Tremelimumab and ,FOLFOX
Sponsor
Centre Georges Francois Leclerc
Collaborators